IONIS PHARMACEUTICALS INC — Form 4
Filed July 9, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
EVP, Chief Scientific Officer BENNETT C FRANK (IONS) sold 36K shares (~$1.7M) on the open market (75% of holdings). Large sale — ~75% of holdings.
Why this rating
Large sale — ~75% of holdings.
See more from July 9, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.